The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Ypsomed Holding, this is the ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Ypsomed Holding AG (VTX:YPSN) as an investment opportunity by estimating the company's future cash ...
LONDON (Reuters) -Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Ypsomed Holding (SWX:YPSN) has recently announced a strategic partnership with Astria Therapeutics to develop an autoinjector for STAR-0215, underscoring its commitment to innovation and enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback